Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)

View source ↗

Summary

Observational study results for bevacizumab (Avastin) in patients with metastatic colorectal cancer (RELEVANT) have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2015-10-16